Blunts: Growth Supplier Moves to New Mexico



A Colorado-based organic gardening supplies giant has announced that it is ending a contract with a chain of hydroponic garden centers in Michigan and has now acquired a gardening supply store in Albuquerque.

According to a press release, GrowGeneration Corp., the nation’s largest chain of specialty hydroponic and organic garden centers, said it was mutually terminating the acquisition of HGS Hydro, a Michigan company that owns a chain of hydroponic gardening suppliers. “After proper due diligence and capital allocation analysis, we have decided to terminate the acquisition,” said Darren Lampert, CEO of GrowGeneration.

In the same release, GrowGeneration announced that it has acquired All Seasons Gardening, an indoor-outdoor garden supplier specializing in hydroponic systems and indoor garden lighting located near I-40 and Jefferson. “The acquisition of All Seasons Gardening is a testament to our continued investment in the best hydroponic suppliers in emerging adult markets for adults in the United States,” said Lampert. “It’s important to note that this represents our entry into the New Mexico cannabis market, which is expected to grow into a billion dollar industry by 2026.”

VA remains opposed to pot research bill

The US Department of Veterans Affairs (VA) has said it will not support a bill that would require it to conduct clinical trials on the medical effectiveness of cannabis.

Last week, lawmakers on the House Veterans Health subcommittee discussed veterans legislation, including the VA Cannabis Research Act, which would direct the VA to conduct clinical trials to test whether cannabis is a viable treatment for veterans with PTSD. The bill would require the VA to sample seven different strains of cannabis for use in studies.

“The proposed legislation is inconsistent with VA’s practice of ensuring scientific merit as the basis for a randomized clinical trial,” VA’s David Carroll said during testimony before the subcommittee. The VA was at odds with the requirement for seven strains and called for “smaller, early phase controlled clinical trials with a focused set of specific goals.”

Gupta explains the position of the pot

During an interview on the “Joe Rogan Experience” podcast, CNN’s Dr. Sanjay Gupta said he publicly changed his stance on cannabis after researching the drug’s medical benefits.

“When you first talked about marijuana you were talking like it had no medical benefit – it was just a recreational drug that maybe or probably was harmful,” said host Joe Rogan.

Gupta said that at the time, over a decade ago, the marijuana studies that were being funded were skewed to look for harm. “If you just looked at the mass of evidence regarding cannabis… in 94% of [studies], the hypothesis was “Where is the harm here?” Show me the wrong. The assumption was not, “Show me the advantage. This was only true for about 6 percent. So right away you are already dealing with a very biased data set.

Gupta told Rogan he changed his mind when he discovered evidence that cannabis was able to reduce the symptoms of epileptic seizures in children.

Josh lee



Leave A Reply